Sponsor:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- Notice of OBSSR Participation in NOT-DA-19-003 "HEAL Initiative: Request for Administrative Supplements to Existing Grants to Accelerate Research on Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630)"
Office of Behavioral and Social Science Research - Notice of Participation of the Office of Research on Womens Health (ORWH) in RFA-HG-19-004, Human Genome Reference Center (HGRC) (U41 Clinical Trial Not Allowed)
Office of Research on Women's Health - Notice of Information: Report on Site Visits to the Veterans Affairs Medical Centers with Focus on Canine Care and Use in Research
National Institutes of Health - Notice of Special Interest on Methodological Advances to Improve Alcohol Measurement and its Consequences for People Living with HIV who have Comorbidities, Coinfections, and Complications
National Institute on Alcohol Abuse and Alcoholism - Request for Information (RFI): Inviting Comments and Suggestions on NIAIDs Antibacterial Resistance Research Framework
National Institute of Allergy and Infectious Diseases - Notice of NIAID Research Objectives added to PAR-19-134 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases - Notice of NIAID Research Objectives added to PAR-18-714 Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases - Pre-Solicitation Notice: NIAID Clinical Research Products Management Center
National Institute of Allergy and Infectious Diseases - Notice of NCCIH's Participation in PA-19-165, "Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)"
National Center for Complementary and Integrative Health - Notice of Request for Information to Better Facilitate Cancer Systems Epidemiology Research
National Cancer Institute - Notice for a Pre-application Webinar for Funding Opportunity Announcement PAR-18-947 "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)"
National Cancer Institute - Notice of Change to Award Information in RFA-CA-19-032 "Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)"
National Cancer Institute - Notice to Clarify NIBIB's Research Objectives Under PAR-19-134, "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)"
National Institute of Biomedical Imaging and Bioengineering - Notice of NHLBI Participation in RFA-TR-19-003 "HEAL Initiative: Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not Allowed)"
National Heart, Lung, and Blood Institute - Notice of Intent to Publish Funding Opportunity Announcement to Improve Care Transitions Through the Use of Interoperable Health Information Technology (R01)
Agency for Healthcare Research and Quality - Notice to Extend PA-17-246
Agency for Healthcare Research and Quality - Notice of Additional Receipt Date for PAR-19-093 "Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)"
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
National Library of Medicine
Office of Behavioral and Social Science Research - Notice of Correction to PA-17-148, Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42)
National Institute of Mental Health - Notice of Change to PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial Optional)
National Center for Advancing Translational Sciences - Notice of Information: NCATS Clinical and Translational Science Awards (CTSA) Programs Interest in Improving Rural Health Outcomes and Eliminating Health Disparities
National Center for Advancing Translational Sciences - Notice of Clarification in Eligibility Requirements for PAR-19-098 Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) and PAR-19-051 Emerging Global Leader Award (K43 Independent Clinical Trial Required)
John E. Fogarty International Center
National Institute of Mental Health
Requests for Applications
- Computational Models of Immunity (U01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- NCI Awardee Skills Development Consortium: Research Education Short Courses (UE5 Clinical Trial Not Allowed)
- NCI Awardee Skills Development Consortium: Program Logistics and Evaluation Coordinating Center (U24 Clinical Trial Not Allowed)
National Cancer Institute
- Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (U01 Clinical Trial Required)
National Institute of Diabetes and Digestive and Kidney Diseases
- Multidisciplinary K12 Urologic Research (KURe) Career Development Program (K12 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
. - Developmental Centers for Interdisciplinary Research in Benign Urology (P20 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- George M. O'Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- Validating Human Stem Cell Cardiomyocyte Technology for Better Predictive Assessment of Drug-Induced Cardiac Toxicity (U01 Clinical Trial Not Allowed)
Food and Drug Administration
- Patient Reported Outcomes Tool Development for Use in Non-Cystic Fibrosis Bronchiectasis Clinical Trials (U01) Clinical Trial Optional
Food and Drug Administration
- Research and Development for Genome Reference Representations (GRR) (U01 Clinical Trial Not Allowed)
National Human Genome Research Institute
- Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18)
Agency for Healthcare Research and Quality
- Addressing the Role of Violence on HIV Care and Viral Suppression (R01 Clinical Trial Optional)
- Addressing the Role of Violence on HIV Care and Viral Suppression (R21 Clinical Trial Optional)
National Institute of Mental Health
Office of Behavioral and Social Science Research
Office of Research on Women's Health
- Addressing the Role of Violence on HIV Care and Viral Suppression (R34 Clinical Trial Optional)
National Institute of Mental Health
Office of Research on Women's Health
- Human Three-Dimensional Cell Model Systems for Alzheimer's Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Institute on Aging
.
Program Announcements
- Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the PDX Development and Trial Centers Research Network (PDXNet) (Admin Supp Clinical Trial Not Allowed)
National Cancer Institute
- Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
- Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed)
- Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Methods Development for Cryogenic or Other Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R21 Clinical Trial Not Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
- High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
NOTE: There is no restriction on the number of applications an institution can submit to the SIG and/or High-End Instrumentation (HEI) Programs each year, provided the applications request different types of equipment. - Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
NOTE: There is no restriction on the number of applications an institution can submit to the SIG and/or High-End Instrumentation (HEI) Programs each year, provided the applications request different types of equipment.
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Lynn Hudachek at lynn-hudachek @uiowa.edu, or Erin Brothers at erin-brothers@uiowa.edu